Skip to content
Open access

The most common epilepsy-causing mutation in EEF1A2 (E122K) perturbs the translation of specific transcripts but not the rate of global protein synthesis

Jul 2026 · bioRxiv · 0 citations · 50 references
Biology

TL;DR

P perturbation of expression of a subset of genes, with a slight skew towards downregulation, in both the translatomic and proteomic datasets indicated a down regulation of proteins involved in synaptic function in both the translatomic and proteomic datasets.

Abstract

Heterozygous de novo missense mutations in the EEF1A2 gene encoding translation elongation factor eEF1A2 result in neurodevelopmental disorders, typically characterised by early onset epilepsy and intellectual disability (ID). The E122K mutation is the most commonly reported missense mutation and is amongst the more severe in terms of epilepsy and ID. Here we made use of a recently developed mouse model which recapitulates the E122K mutation to examine how mutations in EEF1A2 might disrupt neuronal gene expression. Primary neurons from mutant mice and transfected HEK293T cells were used to examine effects on global protein synthesis. In contrast to previous reports, we were unable to detect a change in global protein synthesis using either of two different assay systems. TRAP-seq and mass spectrometry were then employed to study the effects of the mutation on the translatome and proteome respectively. These analyses revealed perturbation of expression of a subset of genes, with a slight skew towards downregulation, particularly for longer transcripts. Further analysis indicated a down regulation of proteins involved in synaptic function in both the translatomic and proteomic datasets.

Read PDF

Similar papers

Open access Sep 2026

Single cell RNA-sequencing reveals neuron type-specific vulnerabilities in a model of STXBP1-related disorder.

Cell-type specific vulnerabilities to STXBP1 haploinsufficiency are identified which may explain hyperexcitability, network dysfunction and cognition deficits in STXBP1-RD, providing potential new therapeutic targets.

A. R. Adam, A. V. van Berkel, M. Vanheusden et al. · 0 citations
Open access Sep 2026

Parkinson's disease-linked D620N mutation selectively alters the brain-specific protein interactome of VPS35.

A comprehensive evaluation of the VPS35 protein interactome is provided and a selective effect of the PD-linked D620N mutation in mammalian cells and brain is revealed, providing key insight into the mechanisms of retromer dysfunction in VPS35-linked PD.

Erin T. Williams, Maxwell Frye, Xi Chen et al. · 0 citations
Open access Aug 2026

Identification of a Novel homozygous Splice-Site Deletion in KCTD7 Gene Associated with Progressive Myoclonic Epilepsy

The particular phenotype that was observed in the patient is comparable to the ones that are described in the KCTD7 related pathologies, combined with segregation analysis indicating both parents carried the variant heterogeneously present is a strong indication that the identified mutation consists of probably pathoge...

S. Alharazy, Peter Natesan Pushparaj, Rose Jelani et al. · 0 citations
Aug 2026

Variants leading to ELAVL2 haploinsufficiency cause a neurodevelopmental disorder with prominent cognitive, behavioral, and neurological features.

An integrative study combining Mendelian genetics, clinical and association studies, and animal and molecular modeling supports variants in ELAVL2 as a cause of a neurodevelopmental disorder, with haploinsufficiency as the disease mechanism, and identifies crucial roles of ELAVL2 in neuronal function, cognition, and be...

Marina Boon, Meghan R. Mulligan, Jolijn J. A. Verseput et al. · 0 citations
Review Open access Sep 2026

A De Novo Gain-of-Function Variant of DNM1L Causes Developmental Encephalopathy.

BACKGROUND Variants in the dynamin 1-like (DNM1L) gene, which encodes dynamin-related protein 1 (Drp1), can cause encephalopathy due to defective mitochondrial and peroxisomal fission 1 (EMPF1) and optic atrophy 5 (OPA5), two neurodevelopmental disorders with distinct symptoms. Given the critical role of Drp1 in mitoch...

Shang-Sheng Dong, Yan-Juan Chen, Meng-Fang Yan et al. · 0 citations
Case report Open access Aug 2026

A case report of a novel de novo variant in PPP2CA causing a neurodevelopmental disorder and epilepsy

The findings support the pathogenicity of this variant and further expand the pathogenic variant spectrum of the PPP2CA gene, and the observed genotype–phenotype correlation provides valuable information for prognosis and genetic counseling.

Lei Xu, Yan-Feng Shen, Guixiang Zhang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.